Ingevity director granted 1,904 RSUs

Ingevity Corp director Luis M. Fernandez-Moreno received an equity award of 1,904 shares of common stock on April 30, 2026.

Rhea-AI Filing Summary

Ingevity Corp director Luis M. Fernandez-Moreno received an equity award of 1,904 shares of common stock on April 30, 2026. The award was granted as restricted stock units under Ingevity Corporation's 2025 Omnibus Incentive Plan and carries no cash exercise price.

The restricted stock units will vest in full on April 30, 2027, meaning the director must remain eligible through that date to receive the shares outright. Following this compensation-related grant, Fernandez-Moreno directly holds 37,882 shares of Ingevity common stock as reported in this filing.

Insider Trade Summary

Grant/Award: 1,904 shares

Grant/Award 1 txn

Insider FERNANDEZ-MORENO LUIS M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,904	$0.00	$0.00

Holdings After Transaction: Common Stock — 37,882 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027.

Key Figures

RSU grant: 1,904 shares Grant price: $0.00 per share Shares after transaction: 37,882 shares +1 more

4 metrics

RSU grant 1,904 shares Restricted stock units granted April 30, 2026

Grant price $0.00 per share Compensation award, not market purchase

Shares after transaction 37,882 shares Direct holdings following Form 4 transaction

Vesting date April 30, 2027 RSUs vest in full on this date

Key Terms

restricted stock units, 2025 Omnibus Incentive Plan, Form 4

3 terms

restricted stock units financial

"Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2025 Omnibus Incentive Plan financial

"pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

Form 4 regulatory

"was reported on a Form 4 insider transaction filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ingevity (NGVT) report for Luis M. Fernandez-Moreno?

Ingevity reported that director Luis M. Fernandez-Moreno received 1,904 shares of common stock as a restricted stock unit grant. The equity award was made as compensation, not a market purchase, and was reported on a Form 4 insider transaction filing.

How many Ingevity (NGVT) shares did Luis M. Fernandez-Moreno receive and at what price?

Luis M. Fernandez-Moreno received 1,904 shares of Ingevity common stock through a restricted stock unit grant at a stated price of $0.00 per share. This reflects a compensation award rather than an open-market transaction, so no cash changed hands for the acquisition.

When will the new Ingevity (NGVT) restricted stock units for Luis M. Fernandez-Moreno vest?

The restricted stock units granted to Luis M. Fernandez-Moreno will vest in full on April 30, 2027. Vesting means the shares become fully owned by him at that date, assuming all plan and service conditions under Ingevity’s 2025 Omnibus Incentive Plan are satisfied.

What is Luis M. Fernandez-Moreno’s total Ingevity (NGVT) shareholding after this Form 4 grant?

After this equity award, Luis M. Fernandez-Moreno directly holds 37,882 shares of Ingevity common stock according to the Form 4. This total includes the newly granted 1,904 restricted stock units reported as part of his director compensation package.

Was the Ingevity (NGVT) Form 4 transaction a stock purchase or a compensation grant?

The Form 4 transaction was a compensation-related grant, not an open-market stock purchase. Luis M. Fernandez-Moreno received 1,904 restricted stock units at $0.00 per share under Ingevity’s 2025 Omnibus Incentive Plan, reflecting an equity award for his role as director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 06:14 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FERNANDEZ-MORENO LUIS M

(Last) (First) (Middle)

4920 O'HEAR AVE

SUITE 400

(Street)

NORTH CHARLESTON SOUTH CAROLINA 29405

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		A		1,904(1)	A	$0	37,882	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units pursuant to Ingevity Corporation's 2025 Omnibus Incentive Plan, which will vest in full on April 30, 2027.

Remarks:

	Luis Fernandez-Moreno By: Mavis G. Huger as Attorney-in-Fact	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)